Article
Association of Atomoxetine Discontinuation Patterns with CYP2D6 Phenotype in Children and Adolescents with Attention Deficit Hyperactivity Disorder.
Journal of child and adolescent psychopharmacology - 1 Oct 2026
Brown Jacob T, Durgin Elise N, Paetznick Courtney, Bishop Jeffrey R, Deonovic Benjamin, Yang Laylia, Watson David A, Gregornik David B
Abstract excerpt
AIMS: The primary aim of this study was to determine whether CYP2D6 phenotypes are associated with atomoxetine treatment outcomes in children and adolescents with attention-deficit hyperactivity disorder. PATIENTS AND METHODS: Patients 21 years and younger with a known CYP2D6 genotype and a prescription for atomoxetine were included in this electronic health record review. The primary outcome was defined as...
Topics
Join the communities discussing this publication.